Outcome of 8-hour dosing intervals with beta-lactam antibiotics in adult acute bacterial meningitis

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 9, 2006, Pages 772-777

  Brink, Magnus ^a   Hagberg, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; MEROPENEM; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; HUMAN; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NEISSERIA MENINGITIDIS; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; SWEDEN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; COMMUNITY-ACQUIRED INFECTIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; MENINGITIS, LISTERIA; MENINGITIS, MENINGOCOCCAL; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33748096111     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600643229     Document Type: Article

References (19)

1. Durand, ML and Calderwood, SB and Weber, DJ and Miller, SI and Southwick, FS and Caviness, VS, Jr and (1993) Acute bacterial meningitis in adults. A review of 493 episodes N Engl J Med, 328, pp. 21-8.
2. Aronin, SI and Peduzzi, P and Quagliarello, VJ. (1998) Community-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing Ann Intern Med, 129, pp. 862-9.
3. Sigurdardottir, B and Bjornsson, OM and Jonsdottir, KE and Erlendsdottir, H and Gudmundsson, S. (1997) Acute bacterial meningitis in adults. A 20-y overview Arch Intern Med, 157, pp. 425-30.
4. Hussein, AS and Shafran, SD. (2000) Acute bacterial meningitis in adults. A 12-y review Medicine (Baltimore), 79, pp. 360-8.
5. Miner, JR and Heegaard, W and Mapes, A and Biros, M. (2001) Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical centre J Emerg Med, 21, pp. 387-92.
6. De Gans, J and van de Beek, D. (2002) Dexamethasone in adults with bacterial meningitis N Engl J Med, 347, pp. 1549-56.
7. Schuchat, A and Robinson, K and Wenger, JD and Harrison, LH and Farley, M and Reingold, AL and (1997) Bacterial meningitis in the United States in 1995. Active Surveillance Team N Engl J Med, 337, pp. 970-6.
8. Flores-Cordero, JM and Amaya-Villar, R and Rincon-Ferrari, MD and Leal-Noval, SR and Garnacho-Montero, J and Llanos-Rodriguez, AC and (2003) Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: Clinical manifestations, management and prognostic factors Intensive Care Med, 29, pp. 1967-73.
9. van de Beek, D and De Gans, J and Spanjaard, L and Weisfelt, M and Reitsma, JB and Vermeulen, M. (2004) Clinical features and prognostic factors in adults with bacterial meningitis N Engl J Med, 351, pp. 1849-59.
10. Kastenbauer, S and Pfister, HW. (2003) Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases Brain, 126, pp. 1015-25.
11. Weightman, NC and Sajith, J. (2005) Incidence and outcome of pneumococcal meningitis in northern England Eur J Clin Microbiol Infect Dis, 24, pp. 542-4.
12. Quagliarello, VJ and Scheld, WM. (1997) Treatment of bacterial meningitis N Engl J Med, 336, pp. 708-16.
13. Begg, N and Cartwright, KA and Cohen, J and Kaczmarski, EB and Innes, JA and Leen, CL and (1999) Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party J Infect, 39, pp. 1-15.
14. Starmark, JE and Stalhammar, D and Holmgren, E. (1988) The Reaction Level Scale (RLS 85). Manual and guidelines Acta Neurochir (Wien), 91, pp. 12-20.
15. Wilson, JT and Pettigrew, LE and Teasdale, GM. (1998) Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use J Neurotrauma, 15, pp. 573-85.
16. Grande, PO and Myhre, EB and Nordstrom, CH and Schliamser, S. (2002) Treatment of intracranial hypertension and aspects on lumbar dural puncture in severe bacterial meningitis Acta Anaesthesiol Scand, 46, pp. 264-70.
17. Lindvall, P and Ahlm, C and Ericsson, M and Gothefors, L and Naredi, S and Koskinen, LO. (2004) Reducing intracranial pressure may increase survival among patients with bacterial meningitis Clin Infect Dis, 38, pp. 384-90.
18. Craig, WA. (1998) Pharmacokinetic/pharmacodynamic parameters: Rationale for anti-bacterial dosing of mice and men Clin Infect Dis, 26, pp. 1-12.
19. Lutsar, I and McCracken, GH, Jr and Friedland, IR. (1998) Antibiotic pharmacodynamics in cerebrospinal fluid Clin Infect Dis, 27, pp. 1117-27.